with (+) or without (-) riboflavin supplementation (RS).
In the riboflavin-supplemented group, the pregnant dams were given 50 mg/L of riboflavin in drinking water from gestational day 0. The P0 Slc52a3-/-pups were sacrificed 5-9 hr after birth, and plasma and tissue concentrations of riboflavin, FMN and FAD were measured by HPLC. All data are expressed as the mean ± SD.
Values where *P < 0.05, **P < 0.01, significantly different from RS (-). (a) Protocol for the animal experiments. Slc52a3+/-mice were mated, and pregnant dams were supplemented with 50 mg/L of riboflavin in drinking water ad libitum from gestational day 0 to 3 weeks postpartum. Newborn pups were also administered 0.75 mg/kg riboflavin subcutaneously once a day until weaning (3-week). From 3 to 5 weeks after birth, the mice received no riboflavin supplementation. (b) Blood glucose level in WT and Slc52a3-/-mice at 3 weeks old (riboflavin-treated condition) or 5 weeks old (riboflavin-untreated condition). Each column represents the mean ± SD (3-week-old WT, n=5; 3-week-old Slc52a3-/-, n=4 5-weekold WT, n=5; 5-week-old Slc52a3-/-, n=5). Values where **P < 0.01 indicate significant difference from controls (WT).
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